Home > Balance Sheet > AARTI PHARMALABS

AARTI PHARMALABS
Balance Sheet

AARTI PHARMALABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Balance Sheet History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
EQUITY AND LIABILITIES
Share Capital ₹45 Cr₹45 Cr₹0.25 Cr₹0.25 Cr
    Equity - Authorised ₹50 Cr₹50 Cr₹0.50 Cr₹0.50 Cr
    Equity - Issued ₹45 Cr₹45 Cr₹0.25 Cr₹0.25 Cr
    Equity Paid Up ₹45 Cr₹45 Cr₹0.25 Cr₹0.25 Cr
    Equity Shares Forfeited ----
    Adjustments to Equity ----
    Preference Capital Paid Up ----
    Face Value ₹5.00₹5.00₹10.00₹10.00
Share Warrants & Outstandings ₹0.23 Cr-₹45 Cr-
Total Reserves ₹1,711 Cr₹1,513 Cr₹1,341 Cr₹-0.02 Cr
    Securities Premium ₹440 Cr₹440 Cr₹440 Cr-
    Capital Reserves ₹89 Cr₹89 Cr₹89 Cr-
    Profit & Loss Account Balance ₹1,086 Cr₹889 Cr₹717 Cr₹-0.02 Cr
    General Reserves ₹88 Cr₹85 Cr₹83 Cr-
    Other Reserves ₹8.32 Cr₹8.77 Cr₹11 Cr-
Reserve excluding Revaluation Reserve ₹1,711 Cr₹1,513 Cr₹1,341 Cr₹-0.02 Cr
Revaluation reserve ----
Shareholder's Funds ₹1,757 Cr₹1,558 Cr₹1,386 Cr₹0.23 Cr
Minority Interest ----
Long-Term Borrowings ----
Secured Loans ₹0.04 Cr₹0.18 Cr₹0.56 Cr-
    Non Convertible Debentures ----
    Converible Debentures & Bonds ----
    Packing Credit - Bank ----
    Inter Corporate & Security Deposit ----
    Term Loans - Banks ----
    Term Loans - Institutions ----
    Other Secured ₹0.04 Cr₹0.18 Cr₹0.56 Cr-
Unsecured Loans ----
    Fixed Deposits - Public ----
    Loans and advances from subsidiaries ----
    Inter Corporate Deposits (Unsecured) ----
    Foreign Currency Convertible Notes ----
    Long Term Loan in Foreign Currency ----
    Loans - Banks ----
    Loans - Govt. ----
    Loans - Others ----
    Other Unsecured Loan ----
Deferred Tax Assets / Liabilities ₹108 Cr₹79 Cr₹71 Cr-
    Deferred Tax Assets ₹2.31 Cr₹1.95 Cr--
    Deferred Tax Liability ₹110 Cr₹81 Cr₹71 Cr-
Other Long Term Liabilities ₹17 Cr₹0.53 Cr₹1.53 Cr-
Long Term Trade Payables ----
Long Term Provisions ₹6.06 Cr₹5.36 Cr--
Total Non-Current Liabilities ₹131 Cr₹85 Cr₹73 Cr-
Current Liabilities ----
Trade Payables ₹378 Cr₹340 Cr₹215 Cr₹0.00 Cr
    Sundry Creditors ₹378 Cr₹340 Cr₹215 Cr₹0.00 Cr
    Acceptances ----
    Due to Subsidiaries- Trade Payables ----
Other Current Liabilities ₹46 Cr₹38 Cr₹12 Cr₹0.00 Cr
    Bank Overdraft / Short term credit ----
    Advances received from customers ₹5.63 Cr₹10 Cr--
    Interest Accrued But Not Due ----
    Share Application Money ----
    Current maturity of Debentures & Bonds ----
    Current maturity - Others ----
    Other Liabilities ₹40 Cr₹28 Cr₹12 Cr₹0.00 Cr
Short Term Borrowings ₹264 Cr₹214 Cr₹338 Cr₹0.02 Cr
    Secured ST Loans repayable on Demands ₹264 Cr₹193 Cr₹13 Cr-
    Working Capital Loans- Sec ₹264 Cr₹193 Cr₹13 Cr-
    Buyers Credits - Unsec ----
    Commercial Borrowings- Unsec ----
    Other Unsecured Loans ₹-264 Cr₹-172 Cr₹312 Cr₹0.02 Cr
Short Term Provisions ₹6.31 Cr₹9.01 Cr₹16 Cr-
    Proposed Equity Dividend ----
    Provision for Corporate Dividend Tax ----
    Provision for Tax -₹3.52 Cr₹7.50 Cr-
    Provision for post retirement benefits ----
    Preference Dividend ----
    Other Provisions ₹6.31 Cr₹5.50 Cr₹8.96 Cr-
Total Current Liabilities ₹694 Cr₹601 Cr₹581 Cr₹0.02 Cr
Total Liabilities ₹2,582 Cr₹2,244 Cr₹2,040 Cr₹0.25 Cr
ASSETS
Gross Block ₹1,609 Cr₹1,431 Cr₹1,225 Cr-
Less: Accumulated Depreciation ₹576 Cr₹505 Cr₹443 Cr-
Less: Impairment of Assets ----
Net Block ₹1,033 Cr₹926 Cr₹782 Cr-
Lease Adjustment A/c ----
Capital Work in Progress ₹78 Cr₹62 Cr₹165 Cr-
Non Current Investments ₹37 Cr₹36 Cr₹32 Cr-
Long Term Investment ₹37 Cr₹36 Cr₹32 Cr-
    Quoted ----
    Unquoted ₹37 Cr₹36 Cr₹32 Cr-
Long Term Loans & Advances ₹29 Cr₹18 Cr₹10 Cr-
Other Non Current Assets ----
Total Non-Current Assets ₹1,236 Cr₹1,081 Cr₹1,012 Cr-
Current Assets Loans & Advances ----
Currents Investments ₹70 Cr₹51 Cr--
    Quoted ₹64 Cr₹28 Cr--
    Unquoted ₹6.49 Cr₹23 Cr--
Inventories ₹643 Cr₹602 Cr₹475 Cr-
    Raw Materials ₹211 Cr₹191 Cr₹191 Cr-
    Work-in Progress ₹129 Cr₹140 Cr₹90 Cr-
    Finished Goods ₹250 Cr₹212 Cr₹190 Cr-
    Packing Materials ₹1.46 Cr₹1.89 Cr₹1.15 Cr-
    Stores  and Spare ₹4.28 Cr₹2.72 Cr₹2.31 Cr-
    Other Inventory ₹48 Cr₹54 Cr₹1.05 Cr-
Sundry Debtors ₹519 Cr₹450 Cr₹377 Cr-
    Debtors more than Six months ₹12 Cr₹33 Cr₹9.21 Cr-
    Debtors Others ₹510 Cr₹419 Cr₹367 Cr-
Cash and Bank ₹24 Cr₹12 Cr₹83 Cr₹0.25 Cr
    Cash in hand ₹0.09 Cr₹0.11 Cr₹0.06 Cr-
    Balances at Bank ₹24 Cr₹12 Cr₹83 Cr₹0.25 Cr
    Other cash and bank balances ----
Other Current Assets ₹17 Cr₹7.70 Cr₹11 Cr-
    Interest accrued on Investments ----
    Interest accrued on Debentures ----
    Deposits with Government ----
    Interest accrued and or due on loans ₹2.22 Cr₹1.12 Cr--
    Prepaid Expenses ₹6.15 Cr₹2.33 Cr₹4.20 Cr-
    Other current_assets ₹8.64 Cr₹4.26 Cr₹6.54 Cr-
Short Term Loans and Advances ₹72 Cr₹40 Cr₹82 Cr-
    Advances recoverable in cash or in kind ₹6.58 Cr₹3.04 Cr--
    Advance income tax and TDS ₹3.44 Cr---
    Amounts due from directors ----
    Due From Subsidiaries ----
    Inter corporate deposits ----
    Corporate Deposits ----
    Other Loans & Advances ₹62 Cr₹37 Cr₹82 Cr-
Total Current Assets ₹1,346 Cr₹1,163 Cr₹1,028 Cr₹0.25 Cr
Net Current Assets (Including Current Investments) ₹651 Cr₹562 Cr₹447 Cr₹0.23 Cr
Miscellaneous Expenses not written off ----
Total Assets ₹2,582 Cr₹2,244 Cr₹2,040 Cr₹0.25 Cr
Contingent Liabilities ₹7.19 Cr₹6.86 Cr--
Total Debt ₹264 Cr₹214 Cr₹339 Cr₹0.02 Cr
Book Value -171.9753,646.609.12
Adjusted Book Value 193.85171.9753,646.609.12

Compare Balance Sheet of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹5,940.2 Cr -0.1% 11.4% 51.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-0.1%

11.4%

51.6%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses